Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Neurourol Urodyn ; 40(1): 256-264, 2021 01.
Article in English | MEDLINE | ID: mdl-33064316

ABSTRACT

AIMS: Postprostatectomy incontinence is a major complication of prostatectomy. Although pelvic floor muscle training can successfully treat postprostatectomy incontinence, evidence for how muscle movement affects continence recovery is lacking. We evaluated dynamic factors of prostatectomy patients using cine magnetic resonance imaging to identify risk factors for postprostatectomy incontinence and reveal the contribution of pelvic floor muscles to continence recovery. METHODS: A total of 128 prostate cancer patients who underwent robot-assisted laparoscopic surgery were enrolled. Cine magnetic resonance imaging was performed preoperatively and 6 months after surgery. Continence was defined as pad-free or use of safety pads. We defined the bladder neck elevation distance during pelvic floor muscle training as the bladder elevation distance. Patients with continence recovery within 1 month comprised the continence group (n = 48); other patients comprised the incontinence group (n = 80). RESULTS: The preoperative bladder elevation distance was significantly longer in the continence group than in the incontinence group (10.4 vs. 8.2 mm; p < .001). The postoperative bladder elevation distance of the continence group tended to be longer (9.9 vs. 8.9 mm; p = .057). Multivariate analysis showed that the preoperative bladder elevation distance significantly contributed to continence recovery (p = .016). Patients with a longer preoperative bladder elevation distance (>8.5 mm) experienced continence recovery significantly faster than patients with a shorter distance (<8.5mm) (p = .038). CONCLUSIONS: Bladder elevation distance, a novel dynamic parameter, was strongly associated with early continence recovery. Cine magnetic resonance imaging can assess a patient's risk of postprostatectomy incontinence and guide pelvic floor muscle training.


Subject(s)
Magnetic Resonance Imaging, Cine/methods , Pelvic Floor/physiopathology , Prostatectomy/adverse effects , Prostatic Neoplasms/complications , Urinary Incontinence/diagnostic imaging , Urinary Incontinence/etiology , Aged , Humans , Male , Middle Aged , Prostatectomy/methods
2.
Nihon Hinyokika Gakkai Zasshi ; 111(1): 1-8, 2020.
Article in Japanese | MEDLINE | ID: mdl-33473089

ABSTRACT

(Objective) Recently, lower urinary tract symptoms (LUTS) were reported to be associated with endothelial dysfunction. Endothelial function is non-invasively measured by flow-mediated dilation (FMD). As tadalafil has the potential to improve atherosclerosis, we evaluated the relationship between LUTS and endothelial function using FMD, and the effects of tadalafil. (Patients and methods) We conducted FMD examinations for a total of 122 males, and analyzed its association with IPSS, OABSS, and cardiovascular risks. Furthermore, 21 BPH patients received 5 mg of tadalafil per day for one year. We defined the Low FMD group as FMD < 3.9% and the Control group as other values, and compared the effects of tadalafil between groups. (Results) In the 122 male patients, FMD was negatively correlated with nocturia and OABSS. Patients with hypertension or coronary artery disease had a lower FMD than those without.In the tadalafil administration study, the Low FMD group achieved greater improvement of IPSS, OABSS and FMD than the Control group. (Conclusion) FMD examination revealed that endothelial dysfunction is closely associated with LUTS in males, and that tadalafil is effective for patients with endothelial dysfunction.


Subject(s)
Blood Flow Velocity , Endothelium, Vascular/drug effects , Lower Urinary Tract Symptoms/diagnosis , Lower Urinary Tract Symptoms/drug therapy , Phosphodiesterase 5 Inhibitors/administration & dosage , Tadalafil/administration & dosage , Vasodilation , Aged , Endothelium, Vascular/physiopathology , Humans , Lower Urinary Tract Symptoms/physiopathology , Male , Middle Aged , Phosphodiesterase 5 Inhibitors/pharmacology , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/physiopathology , Tadalafil/pharmacology , Treatment Outcome , Urinary Bladder, Overactive/drug therapy , Urinary Bladder, Overactive/physiopathology
3.
Nihon Hinyokika Gakkai Zasshi ; 109(2): 85-89, 2018.
Article in Japanese | MEDLINE | ID: mdl-31006746

ABSTRACT

(Purpose) Photoselective vaporization of the prostate (PVP) was introduced in Japan about 10 years ago, and there has been few studies regarding long-term outcomes so far. Herein we report our 10-year follow up result of PVP. (Patients and methods) From January 2006 to June 2006, 31 patients with benign prostatic hyperplasia (BPH) underwent PVP and 20 patients were evaluable in 10 years after PVP. Patients were evaluated preoperatively, at 6 months and at 10 years after surgery by International Prostate Symptom Score (IPSS) and Quality of life score (QOL score). The surgery used 80 watt potassium-titanyl-phosphate laser that was an old model. (Results) The mean IPSS preoperatively, at 6 months and at 10 years was 21.1, 5.5 and 9.4, respectively. The mean QOL score preoperatively, at 6 months and at 10 years was 5.3, 2.2 and 2.5, respectively. Both IPSS and QOL score were significantly improved at 6 months and at 10 years compared with preoperatively. However, among 20 patients re-operation for residual adenoma was required in 4 patients (20%) during the follow-up period. (Conclusion) PVP is an effective method for BPH treatment, allowing sustained long-term improvement of the voiding function.


Subject(s)
Laser Therapy/methods , Lasers, Solid-State/therapeutic use , Prostatic Hyperplasia/surgery , Aged , Humans , Male , Middle Aged , Prostatic Hyperplasia/diagnosis , Quality of Life , Time Factors , Treatment Outcome
4.
Org Lett ; 19(21): 5980-5983, 2017 11 03.
Article in English | MEDLINE | ID: mdl-29063763

ABSTRACT

Three new compounds, designated scopranones A-C, were isolated from the culture broth of a soil isolate, Streptomyces sp. BYK-11038, and shown to be inhibitors of bone morphogenetic protein (BMP) induced alkaline phosphatase activity in a BMP receptor mutant cell line. The structures were elucidated using NMR and other spectral data. The scopranones have an unusual structure with two atypical scooplike moieties linked at the tails to form part of a unique 3-furanone ring.

5.
BJU Int ; 112(1): 131-6, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23432937

ABSTRACT

UNLABELLED: WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Antichollnergic agents are anticipated to diminish storage symptoms, as well as nocturia. Nevertheless, the effect of this treatment on polyuria related to nocturia is not clear. By subgroup analysis of the data set from a phase III clinical trial of antimuscarinic agent for OAB patients in Japan, imidafenacin was found to improve nocturia with a reduction in nocturnal polyuria. This study adds the effects and underlying mechanism of antimuscarinic agents decreasing urine production through inhibition of C-fibre in the bladder of water-leaded rats. OBJECTIVE: To evaluate the effects and underlying mechanisms of antimuscarinic agents used to decrease in urine production in water-loaded rats. SUBJECTS AND METHODS: Urine production was measured using a cystostomy catheter in female Sprague-Dawley rats every 2 h. The effect of the antimuscarinic agents atropine, tolterodine and imidafenacin on urine production was investigated under water-loaded conditions, which were induced by i.p. injection of 15 mL saline. Blood samples were collected to determine the levels of antidiuretic hormone (ADH), aldosterone (ALD), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) before, and 2 and 8 h after, antimuscarinic agent administration. To induce desensitization of C-fibre afferent nerves, resiniferatoxin (RTX)was injected s.c. or intravesically 2 days before experiments. RESULTS: Urine production increased and reached its maximum 2 h after 15 mL saline injection. Imidafenacin and tolterodine decreased urine production in water-loaded rats, but ADH, ALD, ANP and BNP levels were not different between imidafenacin-treated and vehicle-treated rats. The inhibitory effect on urine production was not found in RTX-treated rats. Atropine did not reduce urine production. CONCLUSION: These results suggest that antimuscarinic agents decrease urine volume through C-fibres in the bladder; thus, antimuscarinics with inhibitory effects on C-fibres could be beneficial for nocturia with nocturnal polyuria.


Subject(s)
Muscarinic Antagonists/pharmacology , Nerve Fibers, Unmyelinated/drug effects , Nocturia/drug therapy , Polyuria/drug therapy , Urinary Bladder/innervation , Urodynamics/drug effects , Animals , Disease Models, Animal , Female , Nocturia/physiopathology , Polyuria/physiopathology , Rats , Rats, Sprague-Dawley , Urinary Bladder/drug effects
6.
Nihon Hinyokika Gakkai Zasshi ; 104(6): 712-5, 2013 Nov.
Article in Japanese | MEDLINE | ID: mdl-24564079

ABSTRACT

Two cases of epithelioid angiomyolipoma of the kidney are reported. A 62-year-old female with incidental left renal tumor underwent laparoscopic leftpartial nephrectomy under a diagnosis of renal cell carcinoma. A pathological examination revealed epithelioid angiomyolipoma. The second case was that of a 35-year-old female with back pain. A laparoscopic right nephrectomy revealed epithelioid angiomyolipoma. This recently identified variant of angiomyolipoma is sometimes associated with aggressive clinical behavior including local recurrence and metastasis.


Subject(s)
Angiomyolipoma/diagnosis , Angiomyolipoma/surgery , Kidney Neoplasms/diagnosis , Kidney Neoplasms/surgery , Adult , Angiomyolipoma/pathology , Biomarkers, Tumor/analysis , Diagnosis, Differential , Female , Humans , Kidney Neoplasms/pathology , Laparoscopy/methods , MART-1 Antigen/analysis , Magnetic Resonance Imaging , Melanoma-Specific Antigens/analysis , Nephrectomy/methods , Tomography, X-Ray Computed , Treatment Outcome , gp100 Melanoma Antigen
7.
Low Urin Tract Symptoms ; 3(2): 59-63, 2011 Sep.
Article in English | MEDLINE | ID: mdl-26676387

ABSTRACT

Urgency is the core symptom of the overactive bladder symptom complex, but the underlying mechanisms are not fully understood. Clinical findings have led to the assumption that bladder outlet obstruction (BOO) caused by benign prostatic enlargement (BPE) induces storage symptoms and detrusor overactivity. Presumably, BOO by BPE accounts for urgency; however, urgency is not always caused by BOO. Sensory nerves in the wall of the urethra fire in response to urethral fluid flow, and this activity initiates bladder contractions in the quiescent bladder and augments ongoing contractions in the active bladder. In humans, prostatic urethral anesthesia results in significant increases in bladder capacity among BPH patients without neurological diseases, therefore sensory stimuli from an anatomically altered prostatic urethra has the possibility to induce urgency and detrusor overactivity. Studies in animals demonstrate the basis for an excitatory urethra to bladder reflex. Urethral stimulation by prostaglandin E2 induces an excitatory effect on micturition reflex by activation of C-fiber afferent nerves. α1A -adrenoceptor blocker has an inhibitory effect on the micturition reflex, suggesting excitatory urethra to bladder reflex is mediated by α1A -adrenoceptor. Even if there is no obstruction, increase in urethral sensory due to BPE may induce the development of the detrusor overactivity.

SELECTION OF CITATIONS
SEARCH DETAIL
...